On June 6, 2025, Needham analyst Mike Matson reiterated the "Hold" rating for Medtronic (MDT, Financial). The analyst's decision reflects a consistent stance on the company's stock performance, maintaining the same rating as prior evaluations.
No price target adjustments were reported along with this rating reiteration. As such, the previous price target remains undisclosed. The currency for any future adjustments will be in USD.
This reiteration focuses on Medtronic (MDT, Financial), a prominent player on the NYSE stock exchange. Market participants will likely keep an eye on any future evaluations or potential changes in rating and price targets from analysts and investment firms.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 27 analysts, the average target price for Medtronic PLC (MDT, Financial) is $94.65 with a high estimate of $112.45 and a low estimate of $78.00. The average target implies an upside of 8.80% from the current price of $87.00. More detailed estimate data can be found on the Medtronic PLC (MDT) Forecast page.
Based on the consensus recommendation from 34 brokerage firms, Medtronic PLC's (MDT, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Medtronic PLC (MDT, Financial) in one year is $97.35, suggesting a upside of 11.9% from the current price of $87. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Medtronic PLC (MDT) Summary page.
